effect
quinolon
antimalari
sensit
cell
treat
anthrax
toxin
cell
pretreat
indic
drug
shown
concentr
hour
treat
anthrax
toxin
hour
surviv
measur
mtt
assay
amodiaquin
reduc
cellular
sensit
cell
pretreat
either
dmso
aq
hour
treat
lf
presenc
either
hour
b
figur
effect
amodiaquin
chloroquin
metabolit
activ
host
cathepsin
b
fret
assay
show
activ
cathepsin
b
without
drug
addit
aq
deaq
cq
decq
cell
treat
drug
hour
prior
lysi
determin
cathepsin
b
activ
untreat
cell
lyse
lysat
treat
drug
activ
cathepsin
b
assess
b
screen
assay
ebola
viru
ebov
strain
kikwit
cell
cultur
infect
hela
cell
atcc
cultur
day
corn
flask
cultur
media
contain
minimum
essenti
medium
mem
corn
cellgro
supplement
fetal
bovin
serum
hyclon
lglutammin
hyclon
mm
hepe
sigma
nonessenti
amino
acid
sigma
cell
lift
use
trypsinedta
sigma
cellswel
plate
cultur
media
imag
well
assay
plate
aurora
iqeb
iqebnb
incub
compound
treatment
treatment
cell
test
control
compound
done
h
prior
infect
determin
test
compound
done
fold
step
least
dose
start
highest
concentr
stock
concentr
use
hp
digit
dispens
dose
dispens
directli
concentr
stock
highest
volum
concentr
dmso
well
normal
cell
pretreat
serial
dilut
compound
hour
infect
dose
repeat
time
one
plate
infect
done
use
ebola
viru
kikwit
moi
calcul
cellswel
assum
one
complet
round
replic
hela
cell
hr
cell
seed
viru
dilut
dispens
well
except
column
repres
infect
control
cell
incub
viru
infect
termin
fix
sampl
formalin
solut
immunestain
use
visual
infect
cell
cell
treat
antigp
specif
monoclon
antibodi
dilut
follow
antimous
igg
conjug
thermo
dilut
block
buffer
contain
bsa
pb
nuclei
stain
biostatu
dilut
pb
buffer
imag
acquir
opera
imag
instrument
perkin
elmer
use
air
object
four
imageswel
acquir
signal
antiviru
stain
detect
emiss
wavelength
nuclei
imag
analysi
perform
use
pe
acapella
algorithm
sever
wellbas
output
paramet
measur
includ
number
object
nuclei
posit
viru
number
object
ave
intens
viru
specif
signal
infect
cell
calcul
acapella
directli
viabil
number
object
repres
amount
cell
treat
well
also
use
indic
cytotox
cytostat
effect
number
object
convert
genedata
condeseo
viabil
compound
dose
respons
dose
respons
curv
fit
analysi
analysi
dose
respons
curv
inhibit
viabil
use
determin
ec
cc
appli
genedata
condoseo
softwar
levenbergmarquardt
algorithm
lma
curv
fit
strategi
curvefit
appli
valid
criteria
aschi
se
logec
minim
number
valid
data
point
indic
curv
fit
converg
success
indic
tabl
result
r
valu
quantifi
good
fit
fit
strategi
consid
accept
gave
convers
r
primari
cytopath
effect
cpe
reduct
assay
fourconcentr
cpe
inhibit
assay
perform
confluent
nearconflu
cell
cultur
monolay
dispos
micropl
prepar
cell
maintain
mem
dmem
supplement
fb
requir
cell
line
antivir
assay
medium
use
fb
reduc
less
supplement
gentamicin
test
compound
prepar
four
log
final
concentr
usual
viru
control
cell
control
well
everi
micropl
parallel
known
activ
drug
test
posit
control
drug
use
method
appli
test
compound
posit
control
test
test
run
assay
set
first
remov
growth
media
plate
cell
test
compound
appli
ml
volum
well
concentr
viru
normal
cell
cultur
infecti
dose
ml
volum
place
well
design
viru
infect
medium
devoid
viru
place
toxic
control
well
cell
control
well
viru
control
well
treat
similarli
viru
plate
incub
c
co
maximum
cpe
observ
viru
control
well
plate
stain
neutral
red
approxim
two
hour
c
co
incub
neutral
red
medium
remov
complet
aspir
cell
may
rins
phosphat
buffer
solut
pb
remov
residu
dye
pb
complet
remov
incorpor
neutral
red
elut
sorensen
citrat
ethanol
ph
least
minut
neutral
red
dye
penetr
live
cell
thu
intens
red
color
larger
number
viabl
cell
present
well
dye
content
well
quantifi
use
spectrophotomet
nm
wavelength
dye
content
set
well
convert
percentag
dye
present
untreat
control
well
use
microsoft
excel
computerbas
spreadsheet
effect
ec
virusinhibitori
concentr
cytotox
cc
cellinhibitori
concentr
calcul
linear
regress
analysi
quotient
cc
divid
ec
give
select
index
si
valu
human
foreskin
fibroblast
hff
cell
prepar
human
foreskin
tissu
tissu
incub
h
clinic
medium
place
phosphat
buffer
salin
pb
remov
red
blood
cell
resuspend
trypsinedta
solut
tissu
suspens
incub
gentli
agit
dispers
cell
collect
centrifug
cell
resuspend
ml
clinic
medium
place
flask
incub
humidifi
co
incub
h
media
replac
fresh
clinic
medium
cell
growth
monitor
daili
confluent
monolay
form
hff
cell
expand
serial
passag
standard
growth
medium
mem
earl
salt
supplement
fb
antibiot
cell
passag
routin
use
assay
passag
primari
cytopath
effect
cpe
reduct
assay
low
passag
hff
cell
trypsin
count
seed
well
tissu
cultur
plate
ml
mem
supplement
fb
cell
incub
h
c
media
remov
mem
contain
fb
ad
first
row
first
row
media
contain
experiment
drug
ad
triplic
well
media
alon
ad
cell
viru
control
well
drug
first
row
well
dilut
serial
throughout
remain
plate
incub
min
viru
suspens
ad
well
exclud
cell
control
well
receiv
mem
plate
incub
c
co
incub
three
day
cmv
incub
period
media
aspir
cell
stain
crystal
violet
formalin
stain
remov
plate
rins
excess
stain
remov
plate
allow
dri
h
amount
cpe
row
determin
use
biotek
multipl
autoread
ec
cc
valu
determin
compar
drug
treat
untreat
cell
use
comput
program
confluent
cell
prepar
flask
cell
trypsin
cell
made
cell
suspens
cellsml
cell
suspens
cellswel
ad
well
well
plate
except
row
h
concentr
antivir
made
isoprinosin
test
drug
concentr
point
done
per
well
test
effect
concentr
drug
well
cytotox
concentr
tox
well
ad
rabi
viru
dilut
ad
per
well
drug
well
viru
control
well
gave
final
dilut
final
volum
addit
media
ad
fill
well
ie
tox
well
drug
cell
cellsml
media
plate
cover
incub
co
day
day
promega
celltiterglo
luminesc
cell
viabil
assay
run
use
fluoroskan
fl
scan
luminesc
